Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
8.33
+0.29 (3.54%)
At close: Sep 5, 2025, 4:00 PM
8.00
-0.32 (-3.90%)
After-hours: Sep 5, 2025, 7:47 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $2.61 billion as of September 5, 2025. Its market cap has decreased by -31.67% in one year.
Market Cap
2.61B
Enterprise Value
3.72B
1-Year Change
-31.67%
Ranking
Category
Stock Price
$8.33
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $2.61B, an increase of 755.78%. That is a compound annual growth rate of 56.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 2.61B | -34.66% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | 327.81M | 7.59% |
| Nov 9, 2020 | 304.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |